The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...
Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
The use of GLP-1 receptor agonists, like semaglutide, to treat type 2 diabetes is not associated with an increased risk of ...
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...
Despite a crowded GLP-1 drug development field ... including but not limited to sodium-glucose cotransporter-2 inhibitors. In such a crowded field of developers, Structure is under some pressure ...